Filling the need for trusted information on national health issues…

Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

PATH Malaria Learning Series Examines Population-Wide Drug-Based Strategies To Eliminate Malaria In 3 African Countries

Making Malaria History: PATH Malaria Learning Series: Population-Wide Drug-Based Strategies for Malaria Elimination “Population-wide drug-based strategies are potentially powerful accelerators for malaria elimination. This issue of the PATH Malaria Learning Series explores their role in rapidly reducing the malaria parasite burden in targeted populations and explains the differences between various…

U.S., U.K.-Led Public-Private Partnership To Invest In Antibiotic Research, Development

Financial Times: U.S.-U.K. partnership to tackle antibiotic resistance “A U.S.-U.K. public-private partnership will spend hundreds of millions of dollars over five years to tackle antibiotic resistance, a threat to public health worldwide. The Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator or CARB-X brings together partners including the U.S. government’s Department of…

Progress In Research Made, Funding Shortfalls Persist 6 Months Into Zika Epidemic

The Lancet: The Zika virus public health emergency: 6 months on “…Feb. 1 was a landmark day in the history of the current Zika epidemic. … Since the [WHO’s Public Health Emergency of International Concern (PHEIC)] declaration, scientists have made several unexpected discoveries about the Zika virus. … Many knowledge…

Deaths From Viral Hepatitis Increasing, Data Show

Humanosphere: Hepatitis is on the rise as a global killer Kayla Albrecht, media relations officer at the Institute for Health Metrics and Evaluation, discusses results from a new analysis of viral hepatitis deaths published by The Lancet. Albrecht writes, “More people are dying from viral liver disease than ever before,…

Engaging Religious Leaders In NTD Control, Elimination Efforts Could Help Reduce Poverty

PLOS Neglected Tropical Diseases: The World’s Great Religions and Their Neglected Tropical Diseases Peter J. Hotez, co-editor in chief of PLOS Neglected Tropical Diseases “New information based on data released by the World Health Organization (WHO) indicates that practically everyone infected with a major neglected tropical disease (NTD) lives in…

WHO R&D Blueprint Could Help Create Coherent Global Response To Disease Threats

The Lancet: The need for global R&D coordination for infectious diseases with epidemic potential Marie Paule Kieny, assitant director general of Health Systems and Innovation at the WHO; John-Arne Rottingen, director of the Division of Infectious Disease Control at the Norwegian Institute of Public Health; and Jeremy Farrar, director of…

GMO Technology Integral To Studying Disease Threats

The Conversation: GMOs lead the fight against Zika, Ebola, and the next unknown pandemic Jeff Bessen, PhD candidate at Harvard University “…Most modern biomedical advances, especially the vaccines used to eradicate disease and protect against pandemics such as Zika, Ebola, and the flu, rely on the same molecular biology tools…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.